AVM-associated epilepsy: current state of the problem

Epileptic seizures occur in 20–25 % of patients with cerebral arteriovenous malformations (AVMs) and are often resistant to both surgical and conservative treatment methods. This literature review provides an analysis of current data on the epidemiology, diagnosis, and treatment of epileptic syndrome in patients with cerebral arteriovenous malformations. Over 100 literature sources available in the PubMed, eLibrary.ru, Medscape, Cochrane Library, and Medical NDX databases were analyzed as part of the study. To reflect the most up-to-date information, primary focus was placed on data published between 2018 and 2023.

Special attention in the review is given to modern diagnostic approaches, including the use of neuroimaging and electroencephalography, as well as the latest treatment methods such as stereotactic radiosurgery, endovascular interventions, and combined therapeutic strategies. Factors influencing treatment effectiveness, including the location and size of the AVMs, as well as the clinical course of the epileptic syndrome, are discussed. The review highlights the prospects for further research in this field, aimed at improving patients’ quality of life and reducing the frequency of seizure recurrence. The review emphasizes the need for a multidisciplinary approach to managing patients with cerebral AVMs, as well as the importance of individualized treatment tailored to the specifics of each clinical case.

1. Claro E., Dias A., Girithari G., Massano A., Duarte M. A. Non-traumatic Hematomyelia: A Rare Finding in Clinical Practice. Eur J Case Rep Intern Med. 2018;5(11):000961. Doi: 10.12890/2018_000961.

2. Heit J. J., Thakur N. H., Iv M., Fischbein N. J., Wintermark M., Dodd R. L., Steinberg G. K., Chang S. D., Kapadia K. B., Zaharchuk G. Arterial-spin labeling MRI identifies residual cerebral arteriovenous malformation following stereotactic radiosurgery treatment. J Neuroradiol. 2020;47(1):13–19. Doi: 10.1016/j.neurad.2018.12.004.

3. Wu E. M., El. Ahmadieh T. Y., McDougall C. M., Aoun S. G., Mehta N., Neeley O. J., Plitt A., Shen Ban V., Sillero R., White J. A., Batjer H. H., Welch B. G. Embolization of brain arteriovenous malformations with intent to cure: a systematic review. J Neurosurg. 2019;132(2):388–399. Doi: 10.3171/2018.10.JNS181791.

4. Xu H., Wang L., Guan S., Li D., Quan T. Embolization of brain arteriovenous malformations with the diluted Onyx technique: initial experience. Neuroradiology. 2019;61(4):471–478. Doi: 10.1007/s00234-019-02176-2.

5. Brown R. D. Jr., Wiebers D. O., Torner J. C., O’Fallon W. M. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted Country, Minnesota. J Neurosurg. 1996;85(1):29–32. Doi: 10.3171/jns.1996.85.1.0029.

6. Soldozy S., Akyeampong D. K., Barquin D. L., Norat P., Yağmurlu K., Sokolowski J. D., Sharifi K. A., Tvrdik P., Park M. S., Kalani M. Y. S. Systematic Review of Functional Mapping and Cortical Reorganization in the Setting of Arteriovenous Malformations, Redefining Anatomical Eloquence. Front Surg. 2020;(7):514247. Doi: 10.3389/fsurg.2020.514247.

7. Ding D., Starke R. M., Quigg M., Yen C. P., Przybylowski C. J., Dodson B. K., Sheehan J. P. Cerebral Arteriovenous Malformations and Epilepsy. Part 1: Predictors of Seizure Presentation. World Neurosurg. 2015;84(3):645–52. Doi: 10.1016/j.wneu.2015.02.039.

8. Zhang B., Feng X., Peng F., Wang L., Guo E. K., Zhang Y., Liu P., Wu Z., Liu A. Seizure predictors and outcome after Onyx embolization in patients with brain arteriovenous malformations. Interv Neuroradiol. 2019;25(2):124–131. Doi: 10.1177/1591019918801290.

9. Fisher R. S., Acevedo C., Arzimanoglou A., Bogacz A., Cross J. H., Elger C. E. et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–482. Doi: 10.1111/epi.12550.

10. Fisher R. S., Cross J. H., French J. A., Higurashi N., Hirsch E., Jansen F. E. et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522–530. Doi: 10.1111/epi.13670.

11. Fisher R. S., van Emde Boas W., Blume W.Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470– 472. Doi: 10.1111/j.0013-9580.2005.66104.x.

12. Whelan C. D. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain. 2018;141(2):391–408. Doi: 10.1093/brain/awx341.

13. Hoh B. L., Chapman P. H., Loeffler J. S., Carter B. S., Ogilvy C. S. Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery. 2020;51(2):303–309. PMID: 12182768.

14. Stapf C., Khaw A. V., Sciacca R. R., Hofmeister C., Schumacher H. C., Pile-Spellman J. et al. Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke. 2013;34(11):2664–2669. Doi: 10.1161/01. STR.0000094824.03372.9B.

15. Englot D. J., Young W. L., Han S. J., McCulloch C. E., Chang E. F., Lawton M. T. Seizure predictors and control after microsurgical resection of supratentorial arteriovenous malformations in 440 patients. Neurosurgery. 2012;71(3):572–580. Doi: 10.1227/NEU.0b013e31825ea3ba.

16. Garcin B., Houdart E., Porcher R., Manchon E., SaintMaurice J. P., Bresson D. et al. Epileptic seizures at initial presentation in patients with brain arteriovenous malformation. Neurology. 2012;78(9):626–631. Doi: 10.1212/WNL.0b013e3182494d40.

17. Jiang P., Lv X., Wu Z., Li Y., Jiang C., Yang X. et al. Characteristics of Brain Arteriovenous Malformations Presenting with Seizures without Acute or Remote Hemorrhage. Neuroradiol J. 2019;24(6):886–888. Doi: 10.1177/197140091102400610.

18. Bonaventura A., Vecchie A., Abbate A., Montecucco F. Neutrophil extracellular traps and cardiovascular diseases: an update. Cells. 2020;(9):231. Doi: 10.3390/cells9010231.

19. Galletti F., Costa C., Cupini L. M., Eusebi P., Hamam M., Caputo N. et al. Brain arteriovenous malformations and seizures: an Italian study. J Neurol Neurosurg Psychiatry. 2018;85(3):284–288. Doi: 10.1136/jnnp-2013-305123.

20. Josephson C. B., Leach J. P., Duncan R., Roberts R. C., Counsell C. E., Al-Shahi Salman R. et al. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology. 2021;76(18):1548– 1554. Doi: 10.1212/WNL.0b013e3182190f37.

21. Turjman F., Massoud T. F., Sayre J. W., Vinuela F., Guglielmi G., Duckwiler G. Epilepsy associated with cerebral arteriovenous malformations: a multivariate analysis of angioarchitectural characteristics. AJNR Am J Neuroradiol. 1995;16(2):345–350. PMCID: PMC8338327.

22. van Beijnum J., van der Worp H. B., Buis D. R., Al-Shahi Salman R., Kappelle L. J., Rinkel G. J. E. et al. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA. 2011;306:2011–2019. Doi: 10.1001/jama.2011.1632.

23. Zeal A. A., Rhoton A. L. Jr. Microsurgical anatomy of the posterior cerebral artery. J Neurosurg. 1978;48(4):534– 559. Doi: 10.3171/jns.1978.48.4.0534.

24. Mamonov N. A., Rozhchenko L. V., Goroshchenko S. A., Samochernykh K. A. Relationship between morphometric characteristics of venous drainage of arteriovenous brain malformations and types of clinical course. Translational medicine. 2022;9(3):24–34. (In Russ.). Doi: 10.18705/2311-4495-2022-9-3-24-34.

25. Shankar J. J., Menezes R. J., Pohlmann-Eden B., Wallace C., terBrugge K., Krings T. Angioarchitecture of brain AVM determines the presentation with seizures: proposed scoring system. AJNR Am J Neuroradiol. 2013;34(5):1028–1034. Doi: 10.3174/ajnr.A3361.

26. Shakur S. F., Brunozzi D., Ismail R., Pandey D., Charbel F. T., Alaraj A. Effect of Age on Cerebral Arteriovenous Malformation Draining Vein Stenosis. World Neurosurg. 2018;113:e654–e8. Doi: 10.1016/j.wneu.2018.02.116.

27. Mendoza-Elias N., Shakur S. F., Charbel F. T., Alaraj A. Cerebral arteriovenous malformation draining vein stenosis is associated with atherosclerotic risk factors. J Neurointerv Surg. 2018;10(8):788–790. Doi: 10.1136/neurintsurg-2017-013580.

28. Kim H., Al-Shahi Salman R., McCulloch C. E., Stapf C., Young W. L., Coinvestigators M. Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology. 2019;83(7):590– 597. Doi: 10.1212/WNL.0000000000000688.

29. Derdeyn C. P., Zipfel G. J., Albuquerque F. C., Cooke D. L., Feldmann E., Sheehan J. P., Torner J. C. American Heart Association Stroke Council. Management of Brain Arteriovenous Malformations: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017;48(8):e200–e224. Doi: 10.1161/STR.0000000000000134.

30. Gault J., Sarin H., Awadallah N. A., Shenkar R., Awad I. A. Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery. 2018;55(1):1–16. PMID: 15214969.

31. Rajeswarie R. T., Aravinda H. R., Arivazhagan A., Bevinahalli N. N., Rao M. B., Mahadevan A. Evaluating the Role of Perilesional Tissue in Pathobiology of Epileptogenesis of Vascular Malformations of the Central Nervous System. J Epilepsy Res. 2022;12(2):53–61. Doi: 10.14581/jer.22010.

32. Moftakhar P., Hauptman J. S., Malkasian D., Martin N. A. Cerebral arteriovenous malformations. Part 2: Physiology. Neurosurg Focus. 2019;26(5):E11. Doi: 10.3171/2009.2.FOCUS09317.

33. Haegelen C., Berton E., Darnault P., Morandi X. A revised classification of the temporal branches of the posterior cerebral artery. Surg Radiol Anat. 2020;34(5):385–391. Doi: 10.1007/s00276-011-0921-8.

34. Huberfeld G., Blauwblomme T., Miles R. Hippocampus and epilepsy: Findings from human tissues. Rev Neurol (Paris). 2015;171(3):236–251. Doi: 10.1016/j.neurol.2015.01.563.

35. Ollivier I., Cebula H., Todeschi J., Santin M. D. N., Séverac F., Valenti-Hirsch M. P., Hirsch E., Proust F. Predictive factors of epilepsy in arteriovenous malformation. Neurochirurgie. 2020;66(3):144–149. Doi: 10.1016/j.neuchi.2019.12.009.

36. Ulitin A. Yu., Vasilenko A. V., Ivanenko A. V. et al. Neurophysiological and morphological features of the formation of the pathological hippocampal system in structural epilepsy (literature review). Russian Journal of Personalized Medicine. 2022;2(1):83–92. (In Russ.).

37. Petrov A., Ivanov A., Kolomin E., Tukanov N., Petrova A., Rozhchenko L., Suvorova J. The Advantages of Non-Adhesive Gel-like Embolic Materials in the Endovascular Treatment of Benign Hypervascularized Lesions of the Head and Neck. Gels. 2023;9(12):954. Doi: 10.3390/ gels9120954. PMID: 38131940; PMCID: PMC10742558.

38. Chen C. J., Ding D., Lee C. C., Kearns K. N., Pomeraniec I. J., Cifarelli C. P., Arsanious D. E., Liscak R., Hanuska J., Williams B. J., Yusuf M. B., Woo S. Y., Ironside N., Burke R. M., Warnick R. E., Trifiletti D. M., Mathieu D., Mureb M., Benjamin C., Kondziolka D., Feliciano C. E., Rodriguez-Mercado R., Cockroft K. M., Simon S., Mackley H. B., Zammar S. G., Patel N. T., Padmanaban V., Beatson N., Saylany A., Lee J. Y. K., Sheehan J. P. International Radiosurgery Research Foundation. Stereotactic radiosurgery with versus without prior Onyx embolization for brain arteriovenous malformations. J Neurosurg. 2020;135(3):742–750. Doi: 10.3171/2020.7.JNS201731.

39. Lv X., Wu Z., Li Y., Yang X., Jiang C., Sun Y., Zhang N. Endovascular treatment of cerebral aneurysms associated with arteriovenous malformations. European Journal of Radiology. 2012. Doi: 10.1016/j.ejrad.2011.03.061.

40. Mohr J. P., Parides M. K., Stapf C., Moquete E., Moy C. S., Overbey J. R., Al-Shahi Salman R., Vicaut E., Young W. L., Houdart E., Cordonnier C., Stefani M. A., Hartmann A., von Kummer R., Biondi A., Berkefeld J., Klijn C. J., Harkness K., Libman R., Barreau X., Moskowitz A. J. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614–621. Doi: 10.1016/S0140-6736(13)62302-8.

41. Josephson C. B., Sauro K., Wiebe S., Clement F., Jette N. Medical vs. invasive therapy in AVM-related epilepsy: systematic review and meta-analysis. Neurology. 2016;(86):64–71. Doi: 10.1212/WNL.0000000000002240.

42. Cenzato M. European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH). Acta Neurochir (Wien). 2017;159(6):1059–1064. Doi: 10.1007/s00701-017-3154.

43. Mosimann P. J., Chapot R. Contemporary endovascular techniques for the curative treatment of cerebral arteriovenous malformations and review of neurointerventional outcomes. J Neurosurg Sci. 2018;62(4):505–513. Doi: 10.23736/S0390-5616.18.04421-1.

44. Shovlin C. L., Condliffe R., Donaldson J. W., Kiely D. G., Wort S. J., British Thoracic Society. British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations. Thorax. 2017;72(12):1154–1163. Doi: 10.1136/thoraxjnl-2017-210764.

45. Ironside N., Chen C. J., Ding D., Ilyas A., Kumar J. S., Buell T. J., Taylor D., Lee C. C., Sheehan J. P. Seizure Outcomes After Radiosurgery for Cerebral Arteriovenous Malformations: An Updated Systematic Review and Meta-Analysis. World Neurosurg. 2018;120:550–562.e3. Doi: 10.1016/j.wneu.2018.08.121.

46. Kocer N., Kandemirli S. G., Dashti R., Kizilkilic O., Hanimoglu H., Sanus G. Z., Tunali Y., Tureci E., Islak C., Kaynar M. Y. Single-stage planning for total cure of grade III–V brain arteriovenous malformations by embolization alone or in combination with microsurgical resection. Neuroradiology. 2019;61(2):195–205. Doi: 10.1007/s00234-018-2140-z.

47. Heros R. C., Korosue K., Diebold P. M. Surgical excision of cerebral arteriovenous malformations: late results. Neurosurgery. 1990;26:570–578. Doi: 10.1097/00006123-199004000-00003.

48. Fennell V. S., Martirosyan N. L., Atwal G. S., Kalani M. Y. S., Ponce F. A., Lemole G. M. Jr. et al. Hemodynamics associated with intracerebral arteriovenous malformations: the effects of treatment modalities. Neurosurgery. 2018;83:611–621. Doi: 10.1093/neuros/nyx560.

49. Baranoski J. F., Grant R. A., Hirsch L. J., Visintainer P., Gerrard J. L., Günel M. et al. Seizure control for intracranial arteriovenous malformations is directly related to treatment modality: a meta-analysis. J Neurointerv Surg. 2014;6:684–690. Doi: 10.1136/neurintsurg-2013-010945.

50. Piepgras D. G., Sundt T. M. Jr., Ragoowansi A. T., Stevens L. Seizure outcome in patients with surgically treated cerebral arteriovenous malformations. J Neurosurg. 1993;78:5–11. Doi: 10.3171/jns.1993.78.1.0005.

51. Yeh H. S., Tew J. M. Jr., Gartner M. Seizure control after surgery on cerebral arteriovenous malformations. J Neurosurg. 2003;78:12–18. Doi: 10.3171/jns.1993.78.1.0012.

52. Eliava S., Gorozhanin V., Shekhtman O., Pilipenko Y., Kuchina O. Surgical Treatment of Unruptured Brain AVMs: Short- and Long-Term Results. Acta Neurochir Suppl. 2021;132:87–90. Doi: 10.1007/978-3-030-63453-7_13.

53. Cao Y., Wang R., Yang L., Bai Q., Wang S., Zhao J. Bipolar electrocoagulation on cortex after AVMs lesionectomy for seizure control. Can J Neurol Sci. 2011;38(1):48–53. PMID: 21156429.

54. Hyun S. J., Kong D. S., Lee J. I., Kim J. S., Hong S. C. Cerebral arteriovenous malformations and seizures: differential impact on the time to seizure-free state according to the treatment modalities. Acta Neurochir (Wien). 2012;154(6):1003–1010. Doi: 10.1007/s00701-012-1339-8.

55. Lawton M. T., Rutledge W. C., Kim H., Stapf C., Whitehead K. J., Li D. Y., Krings T., terBrugge K., Kondziolka D., Morgan M. K., Moon K., Spetzler R. F. Brain arteriovenous malformations. Nat Rev Dis Primers. 2015;1:15008. Doi: 10.1038/nrdp.2015.8.

56. Prablek M., LoPresti M. A., Du R., Lam S. Arteriovenous Malformations-Associated Epilepsy in Pediatrics. Childs Nerv Syst. 2021;37(7):2261–2268. Doi: 10.1007/s00381-021-05170-3.

57. Szeifert G. T., Levivier M., Lorenzoni J., Nyáry I., Major O., Kemeny A. A. Morphological observations in brain arteriovenous malformations after gamma knife radiosurgery. Prog Neurol Surg. 2013;27:119–129. Doi: 10.1159/000341772.

58. Hung Y. C., Mohammed N., Eluvathingal Muttikkal T. J., Kearns K. N., Li C. E., Narayan A. et al. The impact of preradiosurgery embolization on intracranial arteriovenous malformations: a matched cohort analysis based on de novo lesion volume. J Neurosurg. Doi: 10.3171/2019.5.JNS19722.

59. Levegrün S., Hof H., Essig M., Schlegel W., Debus J. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters. Int J Radiat Oncol Biol Phys. 2014;59:796–808. Doi: 10.1016/j.ijrobp.2003.11.033.

60. Lv X., Li Y., Jiiang C., Yang X., Wu Z. Brain arteriovenous malformations and endovascular treatment: effect on seizures. Interv Neuroradiol. 2010;16:39–45. Doi: 10.1177/159101991001600105.

61. Chang S. D., Shuster D. L., Steinberg G. K., Levy R. P., Frankel K. Stereotactic radiosurgery of arteriovenous malformations: pathologic changes in resected tissue. Clin Neuropathol. 2007;16:111–116. PMID: 9101115.

62. Yeo S. S., Jang S. H. Delayed neural degeneration following gamma knife radiosurgery in a patient with an arteriovenous malformation: a diffusion tensor imaging study. NeuroRehabilitation. 2012;31:131–135. Doi: 10.3233/NRE-2012-0780.

63. Tu J., Stoodley M. A., Morgan M. K., Storer K. P. Ultrastructure of perinidal capillaries in cerebral arteriovenous malformations. Neurosurgery. 2006;58(5):961–970. Doi: 10.1227/01.NEU.0000210248.39504.B5.

64. Pierot L., Cognard C., Herbreteau D., Fransen H., van Rooij W. J., Boccardi E., Beltramello A., Sourour N., Kupcs K., Biondi A., Bonafé A., Reith W., Casasco A. Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO). Eur Radiol. 2013;23(10):2838– 2845. Doi: 10.1007/s00330-013-2870-6.

65. Jahan R., Murayama Y., Gobin Y. P., Duckwiler G. R., Vinters H. V., Viñuela F. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery. 2015;48:984–997. Doi: 10.1097/00006123-200105000-00003.

66. Andreeva E. S., Panuntsev V. S., Ivanova N. E. Long-term results of embolization of arteriovenous malformations of the brain histoacryloma. Bulletin of Siberian Medicine. 2009;8(3(2)):97–99. (In Russ.).

67. Krivoshapkin A. L., Brusyanskaya A. S., Orlov K. Yu., Gaitan A. S., Sergeev G. S. Control of epileptic seizures in patients with arteriovenous malformations after endovascular treatment. Neurosurgery. 2017;(3):27– 33. (In Russ.).